BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Genetown

  Conagen’s Grant Award Opens New Markets for Monoclonal Antibodies

  The Bill & Melinda Gates Foundation has given a grant to Conagen to support further development of its Conamax platform for the production of accessible low-cost and high-quality monoclonal antibodies, benefitting developing countries and patients globally.

  March 29, 2022

   · 

  3 min read
• Business

  Nuvalent Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results

  Nuvalent, Inc., a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, reported pipeline and business progress and fourth quarter and full year 2021 financial results.

  March 29, 2022

   · 

  8 min read